Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E30.90 EPS (ttm)1.13 Insider Own0.04% Shs Outstand6.07B Perf Week-0.46%
Market Cap211.29B Forward P/E13.19 EPS next Y2.64 Insider Trans-31.03% Shs Float6.06B Perf Month-4.26%
Income6.99B PEG4.52 EPS next Q0.62 Inst Own71.90% Short Float0.65% Perf Quarter1.44%
Sales52.29B P/S4.04 EPS this Y-21.50% Inst Trans-3.06% Short Ratio1.80 Perf Half Y19.39%
Book/sh10.34 P/B3.37 EPS next Y7.27% ROA4.20% Target Price39.47 Perf Year8.44%
Cash/sh3.45 P/C10.09 EPS next 5Y6.84% ROE10.90% 52W Range27.77 - 37.08 Perf YTD10.84%
Dividend1.20 P/FCF34.93 EPS past 5Y1.60% ROI7.30% 52W High-5.26% Beta0.87
Dividend %3.45% Quick Ratio1.10 Sales past 5Y-5.60% Gross Margin77.80% 52W Low26.51% ATR0.43
Employees97900 Current Ratio1.40 Sales Q/Q-62.00% Oper. Margin17.60% RSI (14)49.20 Volatility1.42% 1.20%
OptionableYes Debt/Eq0.70 EPS Q/Q-73.00% Profit Margin13.40% Rel Volume0.64 Prev Close34.82
ShortableYes LT Debt/Eq0.49 EarningsAug 02 BMO Payout101.70% Avg Volume22.01M Price35.13
Recom2.20 SMA20-0.17% SMA50-0.70% SMA2008.70% Volume9,218,201 Change0.89%
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Aug-29-16 01:28PM  Gilead Was Smart to Let Medivation Slip Through its Fingers
12:53PM  Five Healthcare Stocks Hedge Funds Like at Insider Monkey
12:50PM  Mylan To Launch Its Own EpiPen Generic Rival At Half Price
11:05AM  Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
10:05AM  Whats the Story behind the Pfizer-Medivation Deal?
10:00AM  [$$] Mylan to launch cut-price generic version of EpiPen at Financial Times
09:44AM  Why Pfizer Remains Attractively Valued With Medivation at Forbes
08:05AM  What Investors Should Know about the Pfizer-Anacor Deal
12:09AM  Glaxo Bets It Can Shake Up HIV Treatment at The Wall Street Journal
Aug-28-16 02:40PM  [$$] Glaxo Bets It Can Shake Up HIV Treatment at The Wall Street Journal
06:41AM  3 Stocks Up Over 1,000% in the Past 5 Years at Motley Fool
Aug-27-16 06:36PM  Here Are All The Big Biotech Mergers In 2016
Aug-26-16 06:18PM  Can Novartis Tide Over the Alcon Crisis?
09:24AM  Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win
09:20AM  3 Top Stocks For Retirees at Motley Fool
08:02AM  Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move) at Motley Fool
Aug-25-16 03:41PM  Will Pfizer Take a Beating After Its Celebrex Settlement?
03:19PM  Elliott Management Reduced Its Holding in Interpublic Group of Companies
03:18PM  Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal
01:18PM  Pfizer Inks a $1.6 Billion Deal with AstraZeneca at Investopedia
12:04PM  Why Roche Might Be Interested in BioMarin
11:04AM  AstraZenecas Recent Product Developments
10:35AM  Pfizer Can Stall the Decision to Split Thanks to Medivation
09:53AM  Company News for August 25, 2016
09:30AM  Allergan, Humana, Biogen: Billionaires Favorite Healthcare Stocks For Q3 at Insider Monkey
08:45AM  Major Pharma Short Interest Faces Significant Drop at 24/7 Wall St.
08:31AM  How Mylan And Pfizer Could Cause A Major Biotech Backlash at Forbes
12:28AM  [$$] Pfizer Buys Part of AstraZenecas Antibiotics Business at The Wall Street Journal
Aug-24-16 05:27PM  Portfolio Manager: Is Pfizer Acquiring Too Quickly?
05:11PM  Pfizer on buying spree with AstraZeneca antibiotics deal
04:52PM  AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit
04:50PM  Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears
04:03PM  Crude Oil, Health Care Team Up to Pull Wall Street Lower
03:41PM  Dear Pfizer, Stop Overpaying for Acquisitions! at Motley Fool
02:50PM  Stocks Extend Decline as Crude Falls to One-Week Low
02:42PM  Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
02:39PM  Which Criteria Best Determine the Success of Mergers?
01:25PM  AstraZeneca to sell antibiotic pills business to Pfizer
12:59PM  Top trades for the 2nd half: Lending Club, Amgen & more
12:00PM  Pfizer to Buy Rival's Antibiotics Business (PFN) at Investopedia
11:53AM  European Markets Mixed as Volatility Hits 17-Month Low
11:39AM  [$$] Pfizer Buys Part of AstraZeneca's Antibiotics Business at The Wall Street Journal
11:17AM  [$$] Smaller Biotech Buyout Targets After Medivation at Barrons.com
11:04AM  Medivation: The Latest Analyst Recommendations
10:19AM  [$$] AstraZeneca and Pfizer strike $1.6bn antibiotics deal at Financial Times
10:11AM  Market News Over Summer Vacation: PFE, AZN, TSLA, LZB
10:00AM  Write A Prescription For More Pharma M&A With This ETF
09:56AM  Stock Market News for August 24, 2016
09:45AM  AstraZeneca to sell molecule antibiotics business to Pfizer
09:40AM  Stocks Open Flat To Lower As Oil Dips; Lannett Surges, Intuit, Express Dive
09:07AM  Deals of the Day: Pfizer Does Another Deal, Bracing for a September IPO Spike at The Wall Street Journal
09:04AM  Why Pfizer's Latest Deal Could Send Its Shares Soaring
09:00AM  Apple, McDonalds, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2 at Insider Monkey
08:51AM  Stock Futures Little Changed in Wait for Friday's Yellen Speech
08:50AM  AstraZeneca selling antibiotic unit to Pfizer for $725M at bizjournals.com
08:08AM  Early movers: FIT, TSLA, PFE, LZB, CLVS, NMBL & more at CNBC
08:00AM  Pfizer: Let's Stay Together at Bloomberg
08:00AM  Forget About That Pfizer Mega-Merger at Bloomberg
07:27AM  U.S. stock futures search for firm direction, marooned in wait for Yellen at MarketWatch
07:14AM  Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
07:01AM  Pfizer Picks Up AstraZeneca's Antibiotics Business
06:32AM  Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract
06:02AM  5 Things You Must Know Before the Market Opens Wednesday
03:44AM  Pfizer to buy antibiotics business from AstraZeneca Reuters
02:15AM  AstraZeneca to sell antibiotics business to Pfizer Reuters
02:09AM  Pfizer to Buy Antibiotics From AstraZeneca for $725 Million at Bloomberg
02:00AM  Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca Business Wire
Aug-23-16 07:21PM  U.S. Market Indexes Higher on Tuesday
04:27PM  S&P 500, Nasdaq close near records as housing data boosts stocks at MarketWatch
02:39PM  Pfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex? at Barrons.com
11:11AM  Top 6 Pharmaceutical Companies Globally at Investopedia
10:10AM  Stock Market News for August 23, 2016
10:00AM  Top 10 Shareholders of Pfizer (PFE) at Investopedia
09:38AM  Tiger Cub Lee Ainslie Warns About Valuations, Reveals Major Q2 Moves at Insider Monkey
09:30AM  Deals of the Day: Apple Gets a Gliimpse, Pfizer's Steep Price at The Wall Street Journal
09:16AM  Pfizer Expands Cancer Drug Portfolio with the Acquisition of Medivation
09:04AM  Pfizers Medivation Acquisition: What You Need to Know
09:03AM  Your first trade for Tuesday, August 23 at CNBC
08:58AM  Pfizer Has Had A Busy M&A Year...Or Has It?
08:47AM  Medivation (MDVN) Stock Downgraded After Pfizer Deal
08:41AM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
07:45AM  Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China Business Wire
07:01AM  What Pfizer Gets in Its $14 Billion Medivation Deal at Motley Fool
06:59AM  Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Business Wire
04:50AM  Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)
12:23AM  PRESS DIGEST- New York Times business news - Aug 23
12:18AM  PRESS DIGEST - Wall Street Journal - Aug 23 Reuters
12:09AM  [$$] Pfizers Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal
12:09AM  [$$] Pfizer to Buy Medivation for $14 Billion at The Wall Street Journal
12:07AM  [$$] Medivation Ovation: Pfizer Pays the Price for Growth at The Wall Street Journal
Aug-22-16 11:45PM  Asian stocks in summer lull as markets await Yellen speech
11:36PM  M&A is key to Pfizer's sales growth: Strategist
11:05PM  The $150 million winner and the losers in Pfizer's $14 billion takeout of Medivation at bizjournals.com
08:56PM  [$$] Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal at The Wall Street Journal
08:04PM  PRESS DIGEST- British Business - August 23 Reuters
07:24PM  Business Highlights
07:19PM  Pfizer-Medivation cash deal is hard to justify: Analyst
07:02PM  Cramer: Forget biotech! THIS is the next red-hot takeover group at CNBC
07:01PM  Cramer: A Bunch of Semis Are Ripe for the Picking
06:54PM  Stocks Calm As Crude Plunges; Busy Day For Medical Sector
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; and collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., and Merck KGaA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentMay 26Option Exercise24.43100,0002,443,000472,994May 27 11:03 AM
DAMELIO FRANK AExecutive Vice PresidentMay 26Sale34.49100,0003,449,115372,994May 27 11:03 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Option Exercise25.8786,0002,224,820271,663May 26 10:07 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Sale33.9786,0002,921,147185,663May 26 10:07 AM
YOUNG JOHN DGroup PresidentMay 10Option Exercise25.8741,7001,078,779200,399May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Option Exercise24.43192,0004,690,560564,994May 11 06:04 PM
YOUNG JOHN DGroup PresidentMay 10Sale33.5341,7001,398,277158,699May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Sale33.66192,0006,462,579372,994May 11 06:04 PM
READ IAN CChairman & CEOMay 09Option Exercise25.74275,0007,078,2501,471,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Option Exercise22.2823,884532,136199,735May 11 04:35 PM
HILL CHARLES HExecutive Vice PresidentMay 09Sale33.8429,6001,001,65160,828May 11 04:35 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Sale33.7167,8842,288,669131,851May 11 04:35 PM
READ IAN CChairman & CEOMay 09Sale33.80275,0009,295,0391,196,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 05Option Exercise22.2856,0161,248,036231,867May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 05Sale33.7156,0161,888,144175,851May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Option Exercise22.2820,100447,828195,951May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Sale33.8720,100680,762175,851May 06 09:51 AM
DAMELIO FRANK AExecutive Vice PresidentMay 03Sale33.6587,0792,930,208372,994May 05 05:27 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541274,756Feb 26 03:05 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 24Option Exercise18.9062,4531,180,362140,772Feb 26 03:05 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9018,984358,79889,467Feb 26 03:05 PM
READ IAN CChairman & CEOFeb 24Option Exercise18.90584,11211,039,7172,030,151Feb 26 03:05 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541263,151Feb 26 03:05 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9052,570993,573188,679Feb 26 03:05 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9034,171645,832210,943Feb 26 03:05 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90210,2803,974,292622,467Feb 26 03:05 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90210,2803,974,292577,902Feb 26 03:05 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9078,8551,490,360149,135Feb 26 03:05 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9019,188362,65366,048Feb 26 03:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9034,171645,832149,482Feb 26 03:05 PM
BOURLA ALBERTGroup PresidentFeb 24Option Exercise18.9030,666579,587144,675Feb 26 03:03 PM
BOURLA ALBERTGroup PresidentDec 15Option Exercise26.2030,000786,000140,560Dec 16 06:46 PM
YOUNG JOHN DGroup PresidentDec 14Option Exercise26.2031,500825,300163,999Dec 16 06:55 PM
PFIZER INC10% OwnerOct 06Buy7.00714,2854,999,9952,253,509Oct 07 05:42 PM